News: Department of Pharmaceuticals announced the second call for applications under the PRIP Scheme.

About

A Central Sector Scheme under the Ministry of Chemicals & Fertilizers, aimed at shifting India’s pharma sector from volume-based to value-based, innovation-driven growth.

Key Features

• Promotes industry–academia collaboration to develop market-ready products.
• Priority: New medicines (NCEs, NBEs, phytopharmaceuticals), complex generics, biosimilars and novel medical devices.
• Total outlay: ₹5,000 crore.
• Component A: ₹700 crore for Centres of Excellence at 7 NIPERs.
• Component B: ₹4,250 crore for start-ups, MSMEs and large industries.
• Platforms: MedTech Mitra, Patent Mitra and PRIP portal.

Significance: Strengthens R&D, innovation, domestic manufacturing and global competitiveness in India’s pharma-medtech sector.